Sarepta Therapeutics Inc (SRPT)

NASDAQ HEALTHCARE

$17.53 +3.36% RSI 54 Neutral Add Alert

Moving Averages

SMA 200

$19.83

Price below

Company Profile

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$1.60B

P/E Ratio

43.34

EPS

$0.35

Beta

0.205